ADC Therapeutics SA (ADCT) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
ADC Therapeutics SA is the larger company by market cap ($180.0 million vs $176.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADCT | VOGX |
|---|---|---|
| Share price | $1.28 | $11.87 |
| Market cap | $180.05M | $176.33M |
| 1-day change | -1.54% | -7.30% |
| YTD return | -63.74% | — |
| 1-year return | -68.16% | — |
| 5-year return | -94.23% | — |
| EPS (TTM) | $-0.46 | $-0.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $81.36M | — |
| Revenue growth (YoY) | +14.85% | — |
| Net income (latest FY) | $-142.62M | — |
| Gross margin | 92.87% | — |
| Operating margin | -149.34% | — |
| Net margin | -175.31% | — |
| 52-week high | $4.98 | $38.41 |
| 52-week low | $0.78 | $11.51 |
| Distance from 52-week high | -74.30% | -69.10% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +160.16% | +363.35% |
| Average volume | 1.55M | 128.78K |
| Shares outstanding | 140.66M | 14.86M |
| Employees | 188 | 4 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ADC Therapeutics SA
ADCT stock →ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S.
Health Care · Biotechnology: Pharmaceutical Preparations · 188 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
ADCT vs VOGX FAQ
Which is bigger, ADC Therapeutics SA or Vogenx?
ADC Therapeutics SA (ADCT) is larger, with a market capitalization of $180.05M compared with $176.33M for Vogenx (VOGX).
Are ADC Therapeutics SA and Vogenx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.